These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 31071369)

  • 1. Porphyrin-lipid assemblies and nanovesicles overcome ABC transporter-mediated photodynamic therapy resistance in cancer cells.
    Baglo Y; Liang BJ; Robey RW; Ambudkar SV; Gottesman MM; Huang HC
    Cancer Lett; 2019 Aug; 457():110-118. PubMed ID: 31071369
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ABCG2-mediated transport of photosensitizers: potential impact on photodynamic therapy.
    Robey RW; Steadman K; Polgar O; Bates SE
    Cancer Biol Ther; 2005 Feb; 4(2):187-94. PubMed ID: 15684613
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of function of three ABC drug transporters, P-glycoprotein (ABCB1), mitoxantrone resistance protein (ABCG2) and multidrug resistance protein 1 (ABCC1) by tetrahydrocurcumin, a major metabolite of curcumin.
    Limtrakul P; Chearwae W; Shukla S; Phisalphong C; Ambudkar SV
    Mol Cell Biochem; 2007 Feb; 296(1-2):85-95. PubMed ID: 16960658
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reversal of multidrug resistance by Marsdenia tenacissima and its main active ingredients polyoxypregnanes.
    To KKW; Wu X; Yin C; Chai S; Yao S; Kadioglu O; Efferth T; Ye Y; Lin G
    J Ethnopharmacol; 2017 May; 203():110-119. PubMed ID: 28363522
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ABCG2 influence on the efficiency of photodynamic therapy in glioblastoma cells.
    Müller P; Abdel Gaber SA; Zimmermann W; Wittig R; Stepp H
    J Photochem Photobiol B; 2020 Sep; 210():111963. PubMed ID: 32795847
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination of 7-
    Chen Y; Li X; Shi L; Ma P; Wang W; Wu N; Gan Y; Han X; Huang S; Kang X; Liu S; Zhen Y
    Aging (Albany NY); 2022 Sep; 14(17):7156-7169. PubMed ID: 36107024
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Voruciclib, a Potent CDK4/6 Inhibitor, Antagonizes ABCB1 and ABCG2-Mediated Multi-Drug Resistance in Cancer Cells.
    Gupta P; Zhang YK; Zhang XY; Wang YJ; Lu KW; Hall T; Peng R; Yang DH; Xie N; Chen ZS
    Cell Physiol Biochem; 2018; 45(4):1515-1528. PubMed ID: 29486476
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Substrate affinity of photosensitizers derived from chlorophyll-a: the ABCG2 transporter affects the phototoxic response of side population stem cell-like cancer cells to photodynamic therapy.
    Morgan J; Jackson JD; Zheng X; Pandey SK; Pandey RK
    Mol Pharm; 2010 Oct; 7(5):1789-804. PubMed ID: 20684544
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dacomitinib antagonizes multidrug resistance (MDR) in cancer cells by inhibiting the efflux activity of ABCB1 and ABCG2 transporters.
    Fan YF; Zhang W; Zeng L; Lei ZN; Cai CY; Gupta P; Yang DH; Cui Q; Qin ZD; Chen ZS; Trombetta LD
    Cancer Lett; 2018 May; 421():186-198. PubMed ID: 29331420
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ABC transporter (P-gp/ABCB1, MRP1/ABCC1, BCRP/ABCG2) expression in the developing human CNS.
    Daood M; Tsai C; Ahdab-Barmada M; Watchko JF
    Neuropediatrics; 2008 Aug; 39(4):211-8. PubMed ID: 19165709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Photodynamic Therapy Using Photosensitizer-Encapsulated Polymeric Nanoparticle to Overcome ATP-Binding Cassette Transporter Subfamily G2 Function in Pancreatic Cancer.
    Roh YJ; Kim JH; Kim IW; Na K; Park JM; Choi MG
    Mol Cancer Ther; 2017 Aug; 16(8):1487-1496. PubMed ID: 28416605
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new porphyrin as selective substrate-based inhibitor of breast cancer resistance protein (BCRP/ABCG2).
    Zattoni IF; Kronenberger T; Kita DH; Guanaes LD; Guimarães MM; de Oliveira Prado L; Ziasch M; Vesga LC; Gomes de Moraes Rego F; Picheth G; Gonçalves MB; Noseda MD; Ducatti DRB; Poso A; Robey RW; Ambudkar SV; Moure VR; Gonçalves AG; Valdameri G
    Chem Biol Interact; 2022 Jan; 351():109718. PubMed ID: 34717915
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acyl-CoA synthetase-4 is implicated in drug resistance in breast cancer cell lines involving the regulation of energy-dependent transporter expression.
    Orlando UD; Castillo AF; Medrano MAR; Solano AR; Maloberti PM; Podesta EJ
    Biochem Pharmacol; 2019 Jan; 159():52-63. PubMed ID: 30414939
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Breast cancer resistance protein is the enemy of hypericin accumulation and toxicity of hypericin-mediated photodynamic therapy.
    Jendželovský R; Jendželovská Z; Kuchárová B; Fedoročko P
    Biomed Pharmacother; 2019 Jan; 109():2173-2181. PubMed ID: 30551474
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The PI3K subunits, P110α and P110β are potential targets for overcoming P-gp and BCRP-mediated MDR in cancer.
    Zhang L; Li Y; Wang Q; Chen Z; Li X; Wu Z; Hu C; Liao D; Zhang W; Chen ZS
    Mol Cancer; 2020 Jan; 19(1):10. PubMed ID: 31952518
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The tyrosine kinase inhibitor imatinib mesylate enhances the efficacy of photodynamic therapy by inhibiting ABCG2.
    Liu W; Baer MR; Bowman MJ; Pera P; Zheng X; Morgan J; Pandey RA; Oseroff AR
    Clin Cancer Res; 2007 Apr; 13(8):2463-70. PubMed ID: 17438106
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Novel Synthetic Dihydroindeno[1,2-b] Indole Derivative (LS-2-3j) Reverses ABCB1- and ABCG2-Mediated Multidrug Resistance in Cancer Cells.
    Guo C; Liu F; Qi J; Ma J; Lin S; Zhang C; Zhang Q; Zhang H; Lu R; Li X
    Molecules; 2018 Dec; 23(12):. PubMed ID: 30544754
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Strongly amphiphilic photosensitizers are not substrates of the cancer stem cell marker ABCG2 and provides specific and efficient light-triggered drug delivery of an EGFR-targeted cytotoxic drug.
    Selbo PK; Weyergang A; Eng MS; Bostad M; Mælandsmo GM; Høgset A; Berg K
    J Control Release; 2012 Apr; 159(2):197-203. PubMed ID: 22349185
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Desensitization of metastatic melanoma cells to therapeutic treatment through repeated exposure to dacarbazine.
    Biteghe FAN; Padayachee E; Davids LM; Chalomie NET; Ndong JC; Barth S
    J Photochem Photobiol B; 2020 Oct; 211():111982. PubMed ID: 32866820
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug efflux transporters, MRP1 and BCRP, affect the outcome of hypericin-mediated photodynamic therapy in HT-29 adenocarcinoma cells.
    Jendzelovský R; Mikes J; Koval' J; Soucek K; Procházková J; Kello M; Sacková V; Hofmanová J; Kozubík A; Fedorocko P
    Photochem Photobiol Sci; 2009 Dec; 8(12):1716-23. PubMed ID: 20024169
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.